Roquefort Therapeutics (LON:ROQ) Trading 13.8% Higher – Here’s What Happened

Roquefort Therapeutics plc (LON:ROQ)’s stock price was up 13.8% during mid-day trading on Tuesday . The company traded as high as GBX 4.50 ($0.06) and last traded at GBX 4.33 ($0.05). Approximately 1,513,167 shares traded hands during trading, an increase of 174% from the average daily volume of 552,549 shares. The stock had previously closed at GBX 3.80 ($0.05).

Roquefort Therapeutics Stock Performance

The stock’s 50-day moving average is GBX 4.07 and its 200-day moving average is GBX 4.24. The company has a current ratio of 0.79, a quick ratio of 3.07 and a debt-to-equity ratio of 12.37. The stock has a market cap of £5.36 million, a price-to-earnings ratio of -415.00 and a beta of 0.05.

Roquefort Therapeutics Company Profile

Roquefort Therapeutics plc, a biotechnology company, engages in the development of medicines for the treatment of cancer. The company's pre-clinical development pipeline comprises Midkine antibodies with significance in vivo efficacy and toxicology studies; Midkine RNA therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics with novel anti-cancer approach; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo efficacy; and MK cell therapy with direct and NK-mediated anti-cancer action.